Barcelona, Spain: Radiotherapy after breast conserving surgery in conjunction with chemotherapy or tamoxifen to treat early breast cancer reduces the risk of the disease returning in the same breast in the next ten years but makes little difference to that risk thereafter. Nor does it improve overall survival after 30 years. Ian Kunkler, Honorary Professor […]
Ultrasound-guided surgery is quicker, less painful and more effective for treating early form of breast cancer
Barcelona, Spain: Using ultrasound to guide surgery for patients with ductal carcinoma in situ (DCIS) gives better results than the standard technique of using a wire inserted into the breast, according to research presented at the 13th European Breast Cancer Conference. The technique, known as intraoperative ultrasound, or IOUS, enables surgeons to remove a smaller […]
Women with benign breast disease face higher risk of breast cancer in the long term
Barcelona, Spain: The risk of breast cancer is almost doubled in women diagnosed with benign breast disease through screening, according to research presented at the 13th European Breast Cancer Conference. The study of more than 700,000 Spanish women taking part in breast screening compared women who were diagnosed with any benign breast disease, including fibroadenomas […]
Researchers find changes in blood proteins up to two years before breast cancer diagnosis
Barcelona, Spain: Researchers have found changes in the levels of particular proteins in people’s blood up to two years before they were diagnosed with breast cancer. The study, presented at the 13th European Breast Cancer Conference, could form the basis of blood testing for people with a genetic predisposition or a family history of breast […]
Gradual increase in daily activity with psychological therapies can improve mental health for cancer patients and survivors
Barcelona, Spain: Cancer patients and survivors have better mental and physical health and quality of life if they take part in a physical activity programme called ‘behavioural graded activity’ in combination with psychological therapies, according to new research presented at the 13th European Breast Cancer Conference in Barcelona, Spain. Behavioural graded activity involves physiotherapists helping […]
Personalised breast cancer screening could improve cancer survival and reduce overdiagnosis
Barcelona, Spain: Researchers have created a model for predicting individual breast cancer risk that could be used to create personalised breast screening strategies. The research, presented at the 13th European Breast Cancer Conference, could make breast screening programmes more effective and ultimately improve survival rates. It could also mean fewer people experiencing ‘false positives’ – […]
More cancers are diagnosed at an advanced stage if patients already have type 2 diabetes
Barcelona, Spain: A study of 11,945 people in six European countries has shown that people with type 2 diabetes who develop cancer are more likely to be diagnosed with advanced disease if the condition is one that is not screened for routinely. In a presentation to the 13th European Breast Cancer Conference, Dr Anna Jansana, […]
Adversity in childhood is linked to increased risk of heart and blood vessel diseases in early adulthood
Children who experience adversity, including serious family illness or death, poverty, neglect, or dysfunctional and stressful family relationships, are at increased risk of developing diseases of the heart or blood vessels in early adulthood. The new research, which is published in the European Heart Journal [1], is the largest study so far to look at […]
Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer: first results from ARROS-1 phase I clinical trial
Barcelona, Spain: Preliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small cell lung cancer (NSCLC) and other solid tumours, suggest that it may have the potential to both halt tumour growth by inhibiting a cancer-causing gene change, and to reach cancer cells in the brain, with […]
Targeted lung cancer drug shows promise in phase I/II clinical trial
Barcelona, Spain: Early trials of the targeted drug repotrectinib suggest that it could help treat patients with a certain type of non-small cell lung cancer (NSCLC). The results of the TRIDENT-1 trial, which were presented at the 34th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, suggest that repotrectinib could be […]